Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab

Liver Transplantation

Volumn 15, Issue 5, 2009, Pages 540-543

  Singer, Andrew L ^a   Locke, Jamye E ^a   Stewart, Zoe A ^a   Lonze, Bonnie E ^a   Hamilton, James P ^a   Scudiere, Jennifer R ^a   Anders, Robert A ^a   Rother, Russell P ^b   Brodsky, Robert A ^a   Cameron, Andrew M ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ECULIZUMAB; FOLIC ACID; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; WARFARIN; ANTICOAGULANT AGENT; COMPLEMENT COMPONENT C5; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANASTOMOSIS; ANEMIA; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL EMBOLISM; BUDD CHIARI SYNDROME; CASE REPORT; CHOLELITHIASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE COURSE; DRUG DOSE INCREASE; DRUG RESPONSE; ERYTHROCYTE CONCENTRATE; FATIGUE; FLANK PAIN; HAM TEST; HEADACHE; HEMOGLOBINURIA; HEMOLYSIS; HEPATIC ARTERY; HEPATOMEGALY; HUMAN; HYPERTROPHY; KIDNEY FAILURE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVER VEIN OBSTRUCTION; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SPLENOMEGALY; STOMACH VARICES; SURGICAL TECHNIQUE; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN BYPASS; VEIN THROMBOSIS; VOMITING; WEIGHT REDUCTION; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; ILIAC VEIN; IMMUNOLOGY; INFERIOR CAVA VEIN; MESENTERIC VEIN; PORTAL VEIN; TRANSPLANTATION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; BUDD-CHIARI SYNDROME; COMPLEMENT C5; HEMOGLOBINURIA, PAROXYSMAL; HEMOLYSIS; HEPATIC ARTERY; HUMANS; ILIAC VEIN; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MESENTERIC VEINS; PORTAL VEIN; TREATMENT OUTCOME; VENA CAVA, INFERIOR;

EID: 67649950656     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21714     Document Type: Article

References (15)

1. Brodsky RA. Paroxysmal nocturnal hemoglobinuria: the physiology of complement-related hemolytic anemia. Ann Intern Med 2008;148:587-595.
2. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 2004;126:133-138.
3. Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995;333:1253-1258.
4. Socié G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996;348:573-577.
5. Halff G, Todo S, Tzakis AG, Gordon RD, Starzl TE. Liver transplantation for the Budd-Chiari syndrome. Ann Surg 1990;211:43-49.
6. Schattenfroh N, Bechstein WO, Blumhardt G, Langer R, Lobeck H, Langrehr JM, Neuhaus P. Liver transplantation for PNH with Budd-Chiari syndrome. A case report. Transpl Int 1993;6:354-358.
7. Bahr MJ, Schubert J, Bleck JS, Tietge UJ, Boozari B, Schmidt RE, et al. Recurrence of Budd-Chiari syndrome after liver transplantation in paroxysmal nocturnal hemoglobinuria. Transpl Int 2003;16:890-894.
8. Rückert JC, Rückert RI, Rudolph B, Müller JM. Recurrence of the Budd-Chiari syndrome after orthotopic liver transplantation. Hepatogastroenterology 1999;46:867-871.
9. Vivarelli M, La Barba G, Legnani C, Cucchetti A, Bellusci R, Palareti G, Cavallari A. Repeated graft loss caused by recurrent hepatic artery thrombosis after liver transplantation. Liver Transpl 2003;9:629-631.
10. Chang CY, Singal AK, Ganeshan SV, Schiano TD, Lookstein R, Emre S. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl 2007;13:1532-1537.
11. Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L. Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 2007;25:1256-1264.
12. Hillmen P, Young NS, Schubert J, Brodsky RA, Socié G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006;355:1233-1243.
13. Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 2008;111:1840-1847.
14. Hillmen P, Muus P, Dührsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007;110:4123-4128.
15. Brodsky RA, Mukhina GL, Li S, Nelson KL, Chiurazzi PL, Buckley JT, Borowitz MJ. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol 2000;114:459-466.